Alexandra Leconte

635 total citations
30 papers, 288 citations indexed

About

Alexandra Leconte is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Alexandra Leconte has authored 30 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 4 papers in Surgery. Recurrent topics in Alexandra Leconte's work include Cancer survivorship and care (5 papers), Cancer-related cognitive impairment studies (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Alexandra Leconte is often cited by papers focused on Cancer survivorship and care (5 papers), Cancer-related cognitive impairment studies (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Alexandra Leconte collaborates with scholars based in France, Luxembourg and Türkiye. Alexandra Leconte's co-authors include Bénédicte Clarisse, Florence Joly, Natacha Heutte, Stéphanie Lheureux, Sophie Krieger, Laurent Poulain, Mélanie Briand, Marie Lange, Matthieu Meryet‐Figuière and Jean‐Paul Issartel and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Psychology and The Oncologist.

In The Last Decade

Alexandra Leconte

24 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Leconte France 9 91 68 65 63 54 30 288
Peipei Shi China 12 112 1.2× 156 2.3× 58 0.9× 88 1.4× 11 0.2× 36 396
Bogdan Michalski Poland 10 43 0.5× 82 1.2× 43 0.7× 134 2.1× 55 1.0× 20 339
Sayaka Kuba Japan 13 72 0.8× 41 0.6× 58 0.9× 110 1.7× 81 1.5× 44 353
Louise M. Rasmussen Denmark 8 50 0.5× 155 2.3× 54 0.8× 150 2.4× 87 1.6× 8 487
Vicky Kang United States 5 210 2.3× 38 0.6× 62 1.0× 40 0.6× 107 2.0× 12 315
Zhigong Wei China 10 77 0.8× 36 0.5× 38 0.6× 71 1.1× 26 0.5× 44 319
Ana Fröbe Croatia 9 146 1.6× 55 0.8× 24 0.4× 56 0.9× 30 0.6× 41 334
Yanxiang Shao China 12 124 1.4× 86 1.3× 56 0.9× 102 1.6× 42 0.8× 32 356
M. Sattler Netherlands 10 51 0.6× 18 0.3× 70 1.1× 25 0.4× 91 1.7× 21 300

Countries citing papers authored by Alexandra Leconte

Since Specialization
Citations

This map shows the geographic impact of Alexandra Leconte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Leconte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Leconte more than expected).

Fields of papers citing papers by Alexandra Leconte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Leconte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Leconte. The network helps show where Alexandra Leconte may publish in the future.

Co-authorship network of co-authors of Alexandra Leconte

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Leconte. A scholar is included among the top collaborators of Alexandra Leconte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Leconte. Alexandra Leconte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lequesne, Justine, Corinne Delcambre, Angélique Da Silva, et al.. (2023). Does COVID‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital. Cancer Medicine. 12(17). 17603–17612. 1 indexed citations
3.
Heutte, Natacha, Bénédicte Clarisse, Alexandra Leconte, et al.. (2023). Head and neck cancer patients under radiotherapy undergoing skin application of hydrogel dressing or hyaluronic acid: results from a prospective, randomized study. Supportive Care in Cancer. 32(1). 7–7. 3 indexed citations
4.
Coquan, Elodie, Justine Lequesne, Émeline Colomba, et al.. (2022). 2022-RA-579-ESGO A phase II study assessing safety and efficacy of cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure (CABOCOL study). International Journal of Gynecological Cancer. 32. A14–A14.
5.
Santos, Mélanie Dos, Justine Lequesne, Alexandra Leconte, et al.. (2022). Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR). BMC Cancer. 22(1). 537–537. 17 indexed citations
6.
Prévost, Virginie, et al.. (2022). Shared meditation involving cancer patients, health professionals and third persons is relevant and improves well-being: IMPLIC pilot study. BMC Complementary Medicine and Therapies. 22(1). 138–138. 3 indexed citations
7.
Lange, Marie, Bénédicte Clarisse, Alexandra Leconte, et al.. (2022). Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial. BMC Cancer. 22(1). 1308–1308. 6 indexed citations
8.
Noal, Sabine, Natacha Heutte, Bénédicte Clarisse, et al.. (2022). Impact of adjuvant trastuzumab treatment on fatigue, emotional status and quality of personal and work life of patients with localised breast cancer: results of the ‘HER-ception’ study. Supportive Care in Cancer. 31(1). 38–38. 2 indexed citations
9.
Lequesne, Justine, Olivier Rigal, Marianne Leheurteur, et al.. (2022). Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in France. Frontiers in Psychology. 13. 768043–768043. 4 indexed citations
10.
Coquan, Elodie, Pierre-Emmanuel Brachet, Idlir Licaj, et al.. (2021). CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure. BMC Cancer. 21(1). 1054–1054. 3 indexed citations
11.
Prévost, Virginie, et al.. (2021). Meditation involving people with cancer, medical staff and witnesses: a pilot study exploring improvement in wellness and connectedness. BMJ Open. 11(11). e048164–e048164. 2 indexed citations
12.
Bardet, Stéphane, Nicolas Goardon, Justine Lequesne, et al.. (2020). Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study. Endocrine. 71(2). 407–417. 16 indexed citations
13.
Lesueur, Paul, Alexandra Leconte, Julien Geffrelot, et al.. (2020). Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial. BMC Cancer. 20(1). 147–147. 7 indexed citations
15.
16.
Licaj, Idlir, et al.. (2018). Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology. Journal of Geriatric Oncology. 10(2). 235–240. 25 indexed citations
17.
Bardet, Stéphane, Renaud Ciappuccini, Claire Pellot‐Barakat, et al.. (2017). Shear Wave Elastography in Thyroid Nodules with Indeterminate Cytology: Results of a Prospective Bicentric Study. Thyroid. 27(11). 1441–1449. 39 indexed citations
18.
Lange, Marie, Hélène Castel, Natacha Heutte, et al.. (2017). Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. BMC Cancer. 17(1). 110–110. 18 indexed citations
19.
Dugué, Audrey Emmanuelle, Angélina Legros, Alexandra Leconte, et al.. (2016). BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer. Familial Cancer. 16(2). 167–171.
20.
Lheureux, Stéphanie, Sophie Krieger, B. Weber, et al.. (2012). Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile. International Journal of Gynecological Cancer. 22(9). 1483–1488. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026